124
Methods:
The retrospective cohort of HNOs treated from 2007
to 2015 of a tertiary hospital was charted. The therapeutic and
prognostic factors were analysed for overall survival (OS), dis-
ease free survival, local control and metastasis in univariate and
multivariate analysis. The minimum and median period of follow
up was 12 months and 4.67 years.
Findings:
There was a total of 157 patients definitively treated
with surgery in the time period. 7 patients had positive margins
and all were maxillary or skull base tumours. The multivariate
Cox regression showed significance of tumour site (
P
= 0.034),
margin status (
P
= 0.006), chemotherapy (
P
= 0.025), histolog-
ical subtype (
P
= 0.012) as predictors of overall survival. The
margin status (
P
= 0.002), radiotherapy (
P
= 0.005) were signif-
icant predictors for local recurrence. The age and histology
subtype (
P
= 0.058) were borderline significant predictors of
metastasis (
P
= 0.065). The Kaplan–Meier method for OS of dif-
ferent chemotherapy groups (
P
= 0.013), and survival with and
without chemotherapy (
P
= 0.007) was significant. The OS was
significantly better with adjuvant chemotherapy among various
treatment plans (
P
= 0.034).
Conclusion:
Chemotherapy improves OS of HNOs. A random
multi-institute trial is needed to achieve better results.
http://dx.doi.org/10.1016/j.ijom.2017.02.432Postoperative pulmonary failure after oral oncologic surgery
with simultaneous reconstruction
Y. Kakei
∗
, M. Akashi, S. Teraoka, T. Hasegawa,
T. Minamikawa, T. Komori
Department of Oral and Maxillofacial Surgery, Kobe University
Graduate School of medicine, Kobe, Japan
Background:
Postoperative pulmonary failure (PRF) is associ-
ated with significant morbidity and mortality in surgical patients,
but few data exist on the incidence of PRF following oncologic
surgery with simultaneous reconstruction.
Objectives:
To determine the incidence of PRF after oral cancer
resection with simultaneous reconstruction.
Methods:
This retrospective study included who underwent oral
cancer resection with simultaneous reconstruction at the Depart-
ment of Oral andMaxillofacial Surgery, Kobe University Hospital,
between 2007 April and 2015 December. PRF was defined as
having mechanical ventilation longer than 48 h postoperatively,
unplanned postoperative reintubation, or both. Epidemiological
datawere retrospectively gathered fromelectronicmedical records
including age, sex, smoking status, body mass index (BMI), dia-
betes mellitus (DM), duration of surgery, blood loss, intraoperative
transfusion, pre-existent pulmonary diseases, pulmonary function
test. Respiratory failure risk index (RFRI) were retrospectively
obtained for each patient. Univariate test and multivariate analysis
were used to determine statistical significance.
Findings and Conclusions:
Of the 151 patients enrolled, the
overall incidence of PRF was 9% (14/151 patients). BMI, DM,
pre-existent pulmonary diseases, and RFRI are significant in uni-
variate analysis. DM, pre-existent pulmonary diseases and RFRI
are significant in multivariate analysis. We conclude that RFRI
may be useful to detect postoperative PRF in oral major cancer
surgery.
http://dx.doi.org/10.1016/j.ijom.2017.02.433Axillary nodal metastasis in patient with head and neck
carcinoma — a case report
J. Khairi
∗
, A.L. Oo
University of Malaya, Kuala Lumpur, Malaysia
Distant lymph nodes metastasis to axillary nodes in patients with
head and neck squamous cell carcinoma is rare. We report a case
of 62-year-old gentleman presented with right lateral border of
tongue squamous cell carcinoma. Patient was cancer free for 26
years before developing second primary in right parotid. Patient
completed chemotherapy and intensity-modulated radiation ther-
apy prior to surgical resection of the tumour with radical neck
dissection and reconstruction with pectoralis major myocutaneous
flap. In this case report we will discuss regarding possibility of the
axillary node metastasis in head and neck carcinoma and current
review.
http://dx.doi.org/10.1016/j.ijom.2017.02.434Prostate-specific membrane antigen as a possible target for
radionuclide treatment of adenoid cystic carcinoma
T.J.W. Klein Nulent
∗
, B. de Keizer, S.M. Willems, R. de Bree,
R.J.J. van Es
Department of Oral and Maxillofacial Surgery, Head and Neck
Surgical Oncology, Radiology and Nuclear Medicine, and
Pathology, University Medical Center Utrecht, Utrecht, The
Netherlands
Background:
Adenoid cystic carcinoma (AdCC) is an uncommon
malignant epithelial tumour of secretory glands. Many patients
develop slow-growing local recurrences and/or distant metastasis
within ten years, which are responsible for most long-termmorbid-
ity and mortality. Prostate-specific membrane antigen (PSMA), a
transmembrane glycoprotein of prostate epithelial cells, was origi-
nally described as highly prostate-specific. However, radionuclide
imaging using Gallium-68-labelled PSMA and positron emission
tomography (PET)/computed tomography (CT) showed tracer
uptake in several other organs and types of malignancies.
Objective:
We present the results of 68Ga-PSMA-PET/CT imag-
ing and immunohistochemical PSMA expression in patients with
AdCC.
Methods:
Eight patients with known or suspected local recurrent
and/or distant metastatic AdCC underwent full-body 68Ga-
PSMA-11-PET/CT. Standardised uptake values (SUVmax) were
calculated of the regions of recurrent tumour and distant metasta-
sis. Tumour specimens were revised from the pathology archives
and immunohistochemically stained for PSMA expression.
Results:
Four patients developed local recurrence, all suffered dis-
tant metastasis. 7/8 (88%) of the patients depicted PSMA-positive
AdCC on PSMA-PET/CT. In these seven positive PET/CTs, mean
SUVmax was 6.2 for local recurrence and 5.5 for distant metas-
tasis. 6/8 (75%) of primary resection specimens were positive on
PSMA immunohistochemistry. All available specimens of local
recurrent and distant metastatic AdCC showed PSMA expression.
Conclusions:
68Ga-PSMA-PET/CT imaging is a promising and
possibly better imaging modality in staging and follow-up of
AdCC. Until now, curative treatment of deep recurrences or
metastatic AdCC is often impossible. Due to high PSMA expres-
sion of many of these tumours, AdCC might be candidate for




